检索结果 - Eric F. Morand

Refine Results
  1. 1
    New therapeutic target in inflammatory disease: macrophage migration inhibitory factor

    New therapeutic target in inflammatory disease: macrophage migration inhibitory factor 由 Eric F. Morand

    出版 2005
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  2. 2
    Macrophage migration inhibitory factor in rheumatoid arthritis: clinical correlations

    Macrophage migration inhibitory factor in rheumatoid arthritis: clinical correlations 由 Eric F. Morand

    出版 2002
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    It hasn’t gone away: the problem of glucocorticoid use in lupus remains

    It hasn’t gone away: the problem of glucocorticoid use in lupus remains 由 Diane Apostolopoulos, Eric F. Morand

    出版 2016
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  4. 4
    BAFF and innate immunity: new therapeutic targets for systemic lupus erythematosus

    BAFF and innate immunity: new therapeutic targets for systemic lupus erythematosus 由 Fabien B. Vincent, Eric F. Morand, Fabienne Mackay

    出版 2012
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  5. 5
    The BAFF/APRIL system in SLE pathogenesis

    The BAFF/APRIL system in SLE pathogenesis 由 Fabien B. Vincent, Eric F. Morand, Pascal Schneider, Fabienne Mackay

    出版 2014
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  6. 6
    OP0001 The lupus low disease activity state (LLDAS) definition discriminates responders in a systemic lupus erythematosus (SLE) trial: post-hoc analysis of the phase iib muse trial of anifrolumab

    OP0001 The lupus low disease activity state (LLDAS) definition discriminates responders in a systemic lupus erythematosus (SLE) trial: post-hoc analysis of the phase iib muse trial... 由 Eric F. Morand, Anna Berglind, T Sheytanova, Raj Tummala, G. Illei

    出版 2017
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    Comparison of performance of specific (SLEQOL) and generic (SF36) health-related quality of life questionnaires and their associations with disease status of systemic lupus erythematosus: a longitudinal study

    Comparison of performance of specific (SLEQOL) and generic (SF36) health-related quality of life questionnaires and their associations with disease status of systemic lupus erythem... 由 Worawit Louthrenoo, Nuntana Kasitanon, Eric F. Morand, Rangi Kandane‐Rathnayake

    出版 2020
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    Annexin-1 Regulates Macrophage IL-6 and TNF via Glucocorticoid-Induced Leucine Zipper

    Annexin-1 Regulates Macrophage IL-6 and TNF via Glucocorticoid-Induced Leucine Zipper 由 Yuan Yang, Daniel Aeberli, April Dacumos, Jin Xue, Eric F. Morand

    出版 2009
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  9. 9
    Lupus low disease activity state attainment in the phase 3 TULIP trials of anifrolumab in active systemic lupus erythematosus

    Lupus low disease activity state attainment in the phase 3 TULIP trials of anifrolumab in active systemic lupus erythematosus 由 Eric F. Morand, Gabriel Abreu, Richard Furie, Vera Golder, Raj Tummala

    出版 2023
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  10. 10
    Advances in the management of systemic lupus erythematosus

    Advances in the management of systemic lupus erythematosus 由 Eric F. Morand, Ruth Fernandez‐Ruiz, Ashira Blazer, Timothy B. Niewold

    出版 2023
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  11. 11
    Clinical associations of serum interleukin-17 in systemic lupus erythematosus

    Clinical associations of serum interleukin-17 in systemic lupus erythematosus 由 Fabien B. Vincent, Melissa Northcott, Alberta Hoi, Fabienne Mackay, Eric F. Morand

    出版 2013
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  12. 12
    Association of low vitamin D with high disease activity in an Australian systemic lupus erythematosus cohort

    Association of low vitamin D with high disease activity in an Australian systemic lupus erythematosus cohort 由 Kok-Hooi Yap, Melissa Northcott, Alberta Hoi, Eric F. Morand, Mandana Nikpour

    出版 2015
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  13. 13
    Lupus Low Disease Activity State (LLDAS) attainment discriminates responders in a systemic lupus erythematosus trial: <i>post-hoc</i> analysis of the Phase IIb MUSE trial of anifrolumab

    Lupus Low Disease Activity State (LLDAS) attainment discriminates responders in a systemic lupus erythematosus trial: <i>post-hoc</i> analysis of the Phase IIb MUSE trial of anifro... 由 Eric F. Morand, Teodora Trasieva, Anna Berglind, Gabor G. Illei, Raj Tummala

    出版 2018
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  14. 14
    Response to: ‘Comment on: ‘Lupus Low Disease Activity State(LLDAS) attainment discriminates responders in a systemic lupus erythematosus trial: post-hocanalysis of the Phase IIb MUSE trial of anifrolumab’ by Eric Morand et al’ by Isenberg

    Response to: ‘Comment on: ‘Lupus Low Disease Activity State(LLDAS) attainment discriminates responders in a systemic lupus erythematosus trial: post-hocanalysis of the Phase IIb MU... 由 Eric F. Morand, Teodora Trasieva, Anna Berglind, Gabor G. Illei, Raj Tummala

    出版 2018
    获取全文 获取全文
    Carta
    加到收藏夹
    Saved in:
  15. 15
    Role of macrophage migration inhibitory factor (MIF) in murine antigen-induced arthritis: interaction with glucocorticoids

    Role of macrophage migration inhibitory factor (MIF) in murine antigen-induced arthritis: interaction with glucocorticoids 由 Leilani L. Santos, Pamela Hall, Christine N. Metz, Richard Bucala, Eric F. Morand

    出版 2001
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  16. 16
    MIF: Implications in the Pathoetiology of Systemic Lupus Erythematosus

    MIF: Implications in the Pathoetiology of Systemic Lupus Erythematosus 由 Tali Lang, Andrew Foote, Jacinta P. W. Lee, Eric F. Morand, James Harris

    出版 2015
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  17. 17
    Independent association of glucocorticoids with damage accrual in SLE

    Independent association of glucocorticoids with damage accrual in SLE 由 Diane Apostolopoulos, Rangi Kandane‐Rathnayake, Sudha Raghunath, Alberta Hoi, Mandana Nikpour, Eric F. Morand

    出版 2016
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  18. 18
    Perspectives of Patients With Rheumatic Diseases in the Early Phase of <scp>COVID</scp>‐19

    Perspectives of Patients With Rheumatic Diseases in the Early Phase of <scp>COVID</scp>‐19 由 Anna Antony, Kathryn Connelly, Thilinie De Silva, Laura Eades, William Tillett, Sally Ayoub, Eric F. Morand

    出版 2020
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  19. 19
    Patterns and prevalence of cognitive dysfunction in systemic lupus erythematosus

    Patterns and prevalence of cognitive dysfunction in systemic lupus erythematosus 由 Sudha Raghunath, Yifat Glikmann‐Johnston, Fabien B. Vincent, Eric F. Morand, Julie C. Stout, Alberta Hoi

    出版 2023
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  20. 20
    Clinical associations of IL-10 and IL-37 in systemic lupus erythematosus

    Clinical associations of IL-10 and IL-37 in systemic lupus erythematosus 由 Jack Godsell, Ina Rudloff, Rangi Kandane‐Rathnayake, Alberta Hoi, Marcel F. Nold, Eric F. Morand, James Harris

    出版 2016
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: